Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001420506-25-002806
Filing Date
2025-10-02
Accepted
2025-10-02 14:50:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5227
  Complete submission text file 0001420506-25-002806.txt   7125
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Subject) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-80096 | Film No.: 251368291
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4101 COX ROAD SUITE 110 GLEN ALLEN VA 23060
Business Address 4101 COX ROAD SUITE 110 GLEN ALLEN VA 23060 8042704000
CAPITAL MANAGEMENT CORP /VA (Filed by) CIK: 0001074273 (see all company filings)

EIN.: 541048352
Type: SCHEDULE 13G/A